1. Home >
  2. M&A >
  3. Divestiture >
  4. Poland >
  5. Zentiva Acquires Alvogen CEE

M&A Deal Summary

Zentiva Acquires Alvogen CEE

On October 25, 2019, Zentiva acquired life science company Alvogen CEE from Alvogen

Acquisition Highlights
  • This is Zentiva’s 1st transaction in the Life Science sector.
  • This is Zentiva’s 1st transaction in Poland.

M&A Deal Summary
Date 2019-10-25
Target Alvogen CEE
Sector Life Science
Buyer(s) Zentiva
Sellers(s) Alvogen
Deal Type Divestiture

Target

Alvogen CEE

Poland
Alvogen CEE markets over 200 generic and over-the-counter products across multiple therapeutic areas, consisting of highly recognized brands like Lactacyd, Persen, EuBiotic and many more with leading market positions in 14 key markets across CEE including; Russia, Romania, Bulgaria, Hungary, Poland and Balkan markets.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Zentiva

Prague, Czech Republic
Category Company
Sector Life Science
DESCRIPTION

Zentiva is a generics pharmaceutical company, offering generic medicines across all key therapeutic areas. Zentiva is based in Prague, Czech Republic.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: Poland M&A 1 of 1
Year: 2019 M&A 1 of 1

Seller(S) 1

SELLER

Alvogen

Pine Brook, New Jersey, United States
Category Company
Founded 2009
Sector Life Science
DESCRIPTION

Alvogen is a multinational pharmaceuticals company focused on developing, manufacturing, and distributing generic, brand, over-the-counter brands (OTC), and biosimilar products. Alvogen was founded in 2009 and is based in Pine Brook, New Jersey.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: Poland M&A 1 of 1
Year: 2019 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-08-15 Omega Bittner

Moskva, Russia

Omega Bittner is a pharmaceutical firm. Omega Bittner is based in Moskva, Russia.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-01-13 Assertio Therapeutics - Gralise Business

Newark, California, United States

Assertio Therapeutics, Inc. - Gralise Business is a prescription medicine used to treat pain after shingles, or postherpetic neuralgia (PHN).

Buy $128M
Mergr

Solution for

Product

Company

Legal